AUTISM affects many around the world, including carers who selflessly look after loved ones, and is something that isn’t spoken about enough within the Asian community.
To mark World Autism Awareness Day on April 2, Eastern Eye got Jusna Begum to speak about her experience of growing up with an autistic brother.
The devoted sister revealed an emotional lifelong journey with her special sibling.
I am happy to share my story. I have been a carer since the age of 10 to my autistic brother, who is now an adult with a learning disability. I wasn’t prepared for it but have been an informal carer for almost 30 years and juggled it with employment in the outside world.
I have also emotionally supported my parents over the years, to cope with my brother’s demanding disability, due to their lack of knowledge in the early years about autism. I had to read literature and explain facts to them in their native language (Bengali), what autism is and how it’s a lifelong condition.
I am now a 40-year-old British Bangladeshi woman and have lived in Coventry all my life. My brother is now 39 but has the mental capacity of a 4/5-year-old child. He has limited memory and is unable to process information in a normal capacity, with limited speech.
My Bangladesh born parents came over to the UK in the early 1980s. Both had been caught up in the horrific 1971 war, which meant they missed out on schooling midway. This impacted their lives as youngsters, and they were lucky to survive such atrocities.
As children
Both my brother and I were born and raised in the UK. Our parents were young but very savvy and patient during the 1980s, where they struggled financially. My mother always made sure we lived a good childhood behind closed doors. She did her best to normalise my life at the same time.
It wasn’t until 1984 that the primary school where I attended at Coventry (Frederick Birds School), where teachers and other working professionals began to notice that my brother’s ability to function in a classroom environment was challenging and that he was also very slow at learning. The teachers soon consulted with my parents about placing my brother into a special needs school that could meet his specific requirements better.
My brother’s teenage years going into adulthood was far from normal to the outside world. But in my world, it became the norm because as Katie Price once quoted (about her autistic son), Harvey, that he is normal to her because she doesn’t know any different. The reality is that the autism spectrum varies in all individuals on different levels.
Growing up, it was increasingly hard to manage my brother’s challenging behaviour at times, despite working professionals being involved with the family like consultant psychiatrists, speech therapists and social care teams. The reality was a lot harder from day to day. No two days were the same. I found it a real challenge when growing up as a teenager to be able to explain to others why my sibling was so different. I found this to be a challenge particularly in public places like supermarkets and places to eat at. We had to look for autistic friendly places due to my brother’s unpredictable behaviour, so I was always apprehensive about taking him to outdoor venues.
Growing up with a disabled sibling was really tough. The social stigma was particularly hard to deal with, living in an area where there was a large south Asian community. By 20 years of age, I established that a lack of awareness around autism played a large part in the ‘hate crimes’ we experienced daily for almost 18 years from our own community. Many times I had to contact police to report individuals who repeatedly called us nasty names in public, which went on for some time and we had to move home.
This was not only hard to tolerate but at times made me feel quite isolated and cut
off from society. I still had to keep a positive attitude towards the outside world. During the adult stages of my brother’s life, my parents went on to learn about autism by working with professionals. I had to learn to adapt to being able to anticipate how to best manage my brother’s care needs on a day-to-day basis.
My parents have always been his primary carers and they took a real positive attitude to accepting their son’s condition from his early life. I had come into contact with many families over the years, who faced stigma over a disabled relative and felt they had to apologise for it.
I personally feel I have set a good example to my own community by being open about my caring role and how it has not affected my career or life. In my view, if anything, it has made me a better individual in society, where I am able to enrich my brother’s life in more than one way.
He is a happy young man who lives in a world of his own yet expresses his love towards me in a very different way through his interactions. Despite facing challenges, we, as a family, have achieved a lot of progress throughout the last decade by treating my brother like a normal individual. I have played a key role to ensure that he has lived a fulfilling life, by organising care packages to suit his needs.
Now my brother has grown into an adult, he still relies on carers and his family to get through a typical day. I hope my story helps others to see that there is a positive, rewarding side to being a carer and a how you can achieve a better way of coping by working together as a family.
I continue with my caring role today and hope to support young carers of all backgrounds and creed so that they do not suffer with any mental health issues due to feeling isolated. I also wish to thank you for offering to take my story to publish.
Name of Jusna Begum’s brother has not been mentioned to protect his identity. If you are affected by issues raised, visit National Autistic Society on www.autism.org.uk
A new community-led initiative has been launched in the UK to provide culturally sensitive support for South Asian women navigating midlife and menopause.
The Sattva Collective, founded by certified Midlife and Menopause Coach Kiran Singh, officially launched on 14 May 2025 as a registered Community Interest Company (CIC). It is the first initiative in the UK focused specifically on the experiences of South Asian women during what Singh describes as a “deeply personal and often stigmatised” phase of life.
“South Asian women are navigating physical, emotional, and identity shifts in silence – often without the language, space, or support to talk about it,” Singh said. “The Sattva Collective is here to change that. We are reclaiming midlife as a powerful, transformative time – and doing it together.”
The name 'Sattva' is drawn from Sanskrit, referring to clarity, balance, and inner peace – values reflected in the collective’s approach.
The organisation will offer a range of services throughout the year, including:
Monthly community meet-ups in local cafés
Educational workshops on hormone health, mental well-being, and cultural stigma
An annual flagship Midlife Summit launching in January 2026
Public awareness campaigns and digital resources
One-to-one and group coaching sessions
Singh, who is of Indian heritage, aims to address the gaps in both mainstream and cultural conversations around menopause. According to her, many South Asian women face barriers to accessing support due to stigma, lack of awareness, and limited representation in public discourse.
The Sattva Collective is now preparing to roll out its 2025 programme and is actively seeking funding, sponsorship, and community partners to expand its reach and resources.
Describing midlife as “not a crisis, but a calling,” Singh hopes the initiative will empower more women to speak openly about their health and experiences, while building a supportive community.
Further details about upcoming events and resources will be made available through the collective’s official channels in the coming weeks.
Bella Hadid’s return to the Cannes Film Festival was anything but quiet. This year, the model showed up ready to challenge the red carpet rules without actually breaking them.
With new restrictions in place like no sheer fabrics, no visible nudity, no dramatic trains or bulky silhouettes, fashion-watchers wondered if Bella, known for her daring Cannes looks in the past, would tone it down. Instead, she found a clever way around the rules.
Her choice for the opening ceremony? A sleek black Saint Laurent dress with a high slit that climbed nearly to her hip. It was revealing but not banned. The asymmetrical cowl neckline and bare back added to the drama without crossing any lines. Paired with barely-there strappy heels, emerald statement earrings, and a ring, the outfit managed to be both understated and provocative.
Earlier in the day, she’d already turned heads arriving at Hotel Martinez in a white corset top and matching bootcut trousers, another Saint Laurent nod. Her honey-blonde updo, oversized sunglasses, and vintage accessories made it clear that Bella wasn’t here to just blend in.
And while the Met Gala missed her this year, Cannes got the full Hadid effect.
The model’s new hair colour, a shift from brunette to a summery honey blonde, felt like a fresh chapter. Soft waves framed her face, complementing the dark, moody tones of her red carpet outfit. Makeup stayed simple with smokey eyes, matte skin, and nude lips. No theatrics, pure elegance and confidence.
The most impressive part of it all? She managed to follow every rule while still standing out. While some stars played it safe under the stricter dress code, Bella turned the limits into a challenge. No sheer panels? Try bold cut-outs. No dramatic trains? Go for shape-hugging minimalism with impact.
Fashion at Cannes has always been about pushing boundaries. This time, Bella Hadid did it with precision, walking the tightrope between compliance and creativity.
A nationwide recall of five eye care products has been issued in the United States after concerns were raised about their sterility and manufacturing standards. BRS Analytical Services, LLC, the manufacturer of the affected products, has urged consumers to stop using them immediately due to potential safety risks.
The recall, shared in a press release by healthcare distributor AvKARE, affects more than 1.8 million cartons of eye drops. The US Food and Drug Administration (FDA) identified multiple violations during a recent audit, including failures to meet Current Good Manufacturing Practice (CGMP) standards.
CGMP regulations set the minimum requirements for the manufacturing, processing, and packaging of drug products to ensure their safety, quality, and efficacy. The FDA stated there is a “lack of assurance of sterility” in the recalled items, which could pose serious health risks to users.
The following products have been included in the recall:
Artificial Tears Ophthalmic Solution
Carboxymethylcellulose Sodium Ophthalmic Gel 1%
Carboxymethylcellulose Sodium Ophthalmic Solution
Lubricant Eye Drops Solution
Polyvinyl Alcohol Ophthalmic Solution
Although the company has not specified the exact health risks, it warned that the products are of “unacceptable quality” and that “it’s not possible to rule out patient risks resulting from use of these products.”
The recalled products were distributed from 26 May 2023 to 21 April 2025. Consumers in possession of any of the affected items are advised to discontinue use immediately and either return them to the place of purchase for a full refund or dispose of them safely.
Customers are also encouraged to complete and submit the recall notice form, including the “Quantity to Return” section and their contact details. These can be sent via fax or email to AvKARE, even if the products are no longer in their possession.
The FDA has categorised the recall as a Class II, meaning there is a reasonable probability that use of the products could result in temporary or medically reversible adverse health effects, or that serious harm is unlikely but possible.
Keep ReadingShow less
This may influence future decisions on treatment options for obesity patients
Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.
This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.
The results revealed that Zepbound helped nearly 25% more participants achieve a weight loss of over 15% compared to Wegovy. In addition, Zepbound demonstrated a more significant reduction in waist circumference, with an average decrease of 18.4 cm. In comparison, Wegovy participants saw an average reduction of 13 cm.
Novo Nordisk, in a statement sent via email on Monday, pointed out that the weight loss achieved by Wegovy in this trial was lower than what was observed in a 2021 trial with a similar dose. However, the company emphasised that Wegovy is the only GLP-1 agonist medicine approved to prevent major cardiovascular events, such as heart attacks, a critical benefit for patients with obesity. Novo also mentioned that a trial with a higher dose of semaglutide, Wegovy's active ingredient, conducted earlier this year, showed greater weight-loss results.
Lilly had previously reported in December that its obesity drug had already surpassed Wegovy, with patients treated with Zepbound losing 47% more weight than those who received Wegovy. These findings were also shared in a press release and presented at the European Congress on Obesity.
The timing of the trial results coincides with a recent decision by CVS Health to exclude Zepbound from some of its reimbursement lists, preferring Wegovy instead. This move highlights the ongoing competition between the two pharmaceutical giants in the obesity treatment space.
Zepbound mimics two gut hormones to support weight loss, while Wegovy relies on a single mode of action. In separate trials, Lilly's Zepbound helped patients lose more than 22% of their body weight after 72 weeks, while Wegovy led to a 15% reduction in weight after 68 weeks.
The growing competition in the weight-loss drug market is also impacted by another Eli Lilly medication, Mounjaro, which has shown positive results for diabetes and weight loss. With these advancements, Eli Lilly is positioning itself as a major player in the obesity treatment landscape.
These results reflect the growing rivalry in the weight-loss drug market and may influence future decisions on treatment options for obesity patients.
Keep ReadingShow less
The WHO forecasts a continued reduction in the global nursing shortage
The global nursing workforce has grown by nearly two million over the past five years, yet major disparities in distribution continue to impede progress towards universal health coverage (UHC) and global health goals, according to the State of the World’s Nursing 2025 report released on 12 May by the World Health Organization (WHO), International Council of Nurses (ICN), and partners.
As of 2023, there are 29.8 million nurses worldwide, up from 27.9 million in 2018. The report also notes a decline in the global nursing shortage, from 6.2 million in 2020 to 5.8 million in 2023. However, the report cautions that the improvements are not evenly shared across regions and income levels, leaving many low- and middle-income countries struggling with persistent shortfalls.
A striking imbalance in nurse distribution persists: 78 per cent of the world’s nurses are based in countries that account for just 49 per cent of the global population. High-income nations host nearly half the global nursing workforce, despite representing only 17 per cent of the world’s population. This concentration has raised concerns that many countries are being left behind, particularly in Africa and the Eastern Mediterranean, where shortages are expected to remain critical.
The WHO forecasts a continued reduction in the global nursing shortage, projecting a shortfall of 4.1 million by 2030. However, almost 70 per cent of this gap is expected to be concentrated in the African and Eastern Mediterranean regions, which could seriously undermine healthcare delivery and preparedness for future health emergencies.
Low-income countries are seeing faster growth in nurse graduate numbers, yet many face challenges in translating this into increased nurse availability. Factors such as rapid population growth, limited job creation, and restricted resources mean these countries are unable to retain and integrate newly qualified nurses into the workforce. The report urges governments to prioritise domestic investment in health systems to ensure graduate absorption and improve employment conditions.
Meanwhile, high-income countries are experiencing a demographic shift in their nursing workforce. Around 19 per cent of nurses globally are expected to retire within the next decade. In some high-income nations, retirements are likely to exceed new entrants, raising the risk of workforce gaps and reduced mentoring capacity for younger nurses.
International migration continues to play a key role in shaping nursing workforces. Globally, one in seven nurses is foreign-born, with high-income countries depending on international recruitment for nearly a quarter of their workforce. By contrast, foreign-born nurses make up only 1–8 per cent of the workforce in lower-income countries. The report calls for stronger bilateral agreements to ensure ethical recruitment and mutual benefits for both source and destination countries.
Gender equity remains a central concern. Women comprise 85 per cent of the global nursing workforce, yet opportunities for advancement and leadership remain limited in many settings. While 82 per cent of countries report having a senior government nursing officer, only 25 per cent of low-income countries offer structured leadership development programmes for nurses.
The report also highlights progress in recognising advanced nursing roles, with 62 per cent of countries now reporting the existence of such positions, up from 53 per cent in 2020. Advanced practice nurses have been shown to enhance access to care, particularly in underserved areas.
Mental health and wellbeing support for nurses remains inadequate. Despite increased workloads and stress during the COVID-19 pandemic, only 42 per cent of countries surveyed have formal provisions for mental health support. The lack of such measures is seen as a barrier to retaining experienced staff and ensuring quality care.
The State of the World’s Nursing 2025 report sets out key policy recommendations for the 2026–2030 period. These include expanding and equitably distributing nursing jobs, aligning education systems with workforce needs, improving pay and working conditions, and strengthening regulation and leadership. Additional priorities focus on preparing nurses for digital healthcare delivery, addressing gender pay gaps, and supporting those working in conflict zones and climate-affected areas.
Pam Cipriano, President of the ICN, said the report served as an “important milestone” in tracking global efforts to strengthen nursing. “Delivering on UHC depends on recognising the true value of nurses and empowering them to lead health system improvements,” she said.
WHO Director-General Dr Tedros Adhanom Ghebreyesus welcomed the progress but warned that deep inequalities persist. “This report is a guide to where we are and what we must do next,” he said. “Countries must act quickly to close the gaps and support the nursing workforce.”
The report draws on data from 194 countries and is part of WHO’s efforts to monitor and strengthen the global health workforce as part of the push to meet the Sustainable Development Goals by 2030.